Why it matters: The effectiveness gap could always disappear with more data, and both vaccines remain very effective against severe disease.

But if the gap does hold up, it raises questions about whether the two vaccines should be treated the same way policy-wise.

Stay on top of the latest market trends and economic insights with Axios Markets.